Private Equity

Updated:

Longwin Capital

Longwin Capital is an investment management company that manages multiple equity investment funds. It focuses on AI, healthcare, new energy, and blockchain...

Longwin Capital logo

Longwin Capital

Longwin Capital is an investment management company that manages multiple equity investment funds. It focuses on AI, healthcare, new energy, and blockchain industries. Longwin Capital has made 5 investments, including a Series A investment in Sesame Blossom Medical on April 30, 2021.

General information

Firm type

Private Equity

Year founded

2015

Location

Region

Asia

Country

China

City

Shanghai

Corporate office

Shanghai, China

Frequently asked questions

What investment stages does Longwin Capital target?

Longwin Capital's mandate spans the full corporate lifecycle. The firm invests in seed and startup venture rounds, growth and expansion equity, late-stage pre-IPO placements, PIPE transactions in publicly listed companies, and full buyouts. This multi-stage structure is atypical among Chinese private equity managers, which generally separate early- and late-stage strategies into distinct fund vehicles. The approach allows Longwin to maintain exposure to portfolio companies from formation through listing without requiring handoffs between separate teams.

Who runs investment decisions at Longwin Capital?

Longwin Capital has not publicly disclosed the identities of its founders, managing partners, or investment committee members. This is consistent with the operational posture of many mid-market Chinese private equity firms that raise capital through domestic relationships rather than international institutional fundraising. No named principals appear in accessible regulatory filings, press releases, or the firm's website as of this profile's compilation date.

How does Longwin Capital source its deals?

Based on its Shanghai headquarters and multi-stage mandate, Longwin likely sources deals through domestic broker-dealer networks, direct founder relationships, and referrals from securities firms that underwrite Chinese IPOs. The firm's ability to invest across seed, growth, pre-IPO, and PIPE stages suggests deep relationships with China's financial intermediaries. However, Longwin has not publicly described a proprietary sourcing model, and no performance or portfolio data is available to verify the composition or quality of its deal flow.

Does Longwin Capital participate in fund commitments or only direct deals?

Publicly available information indicates Longwin Capital executes direct investments across equity stages rather than operating as a fund-of-funds. The firm's disclosed strategy tags include direct venture, growth, buyout, and PIPE transactions in operating companies. No evidence suggests Longwin allocates capital as a limited partner into externally managed private equity or venture capital funds, though the firm's limited disclosures mean this cannot be ruled out definitively.

What is Longwin Capital's known track record or portfolio?

Longwin Capital has not publicly disclosed its portfolio companies, investment track record, fund performance, or assets under management. The firm maintains a minimal web presence and does not issue press releases through international newswires. This opacity is common among Chinese private equity managers that raise capital domestically and are not subject to public disclosure requirements. Without access to Chinese-language regulatory filings or direct communication with the firm, portfolio composition and historical returns remain unverifiable.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Shanghai Private Equity profiles